enVVeno Medical Corp Operating Lease Cost
enVVeno Medical Corp (NVNO) reported Operating Lease Cost of $389.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-03-26
- enVVeno Medical Corp operating lease, cost for the quarter ending 2021-12-31 was $89.38K, a 4.55% increase year-over-year.
- enVVeno Medical Corp operating lease, cost for the quarter ending 2021-09-30 was $85.49K, a 0.00% change year-over-year.
- enVVeno Medical Corp operating lease, cost for the quarter ending 2021-06-30 was $85.49K, a 0.00% change year-over-year.
- enVVeno Medical Corp operating lease, cost for the quarter ending 2021-03-31 was $85.49K, a 0.00% change year-over-year.
- enVVeno Medical Corp operating lease, cost for fiscal 2025 was $389.00K, a 0.00% change from fiscal 2024.
- enVVeno Medical Corp operating lease, cost for fiscal 2024 was $389.00K, a 0.00% change from fiscal 2023.
- enVVeno Medical Corp operating lease, cost for fiscal 2023 was $389.00K, a 0.00% change from fiscal 2022.
- enVVeno Medical Corp operating lease, cost for fiscal 2022 was $389.00K, a 12.47% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $389.00K 10-K · filed 2026-03-26 | |||
| 2024-12-31 | $389.00K 10-K · filed 2025-02-28 | |||
| 2023-12-31 | $389.00K 10-K · filed 2024-02-29 | |||
| 2022-12-31 | $389.00K 10-K · filed 2023-03-02 | |||
| 2021-12-31 | $89.38K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $174.87K derived: sum of 2 quarters · filed 2022-03-28 | $260.37K derived: sum of 3 quarters · filed 2022-03-28 | $345.86K 10-K · filed 2022-03-28 |
| 2021-09-30 | $85.49K 10-Q · filed 2021-11-12 | $170.98K derived: sum of 2 quarters · filed 2021-11-12 | $256.48K 10-Q · filed 2021-11-12 | $341.97K derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | $85.49K 10-Q · filed 2021-08-11 | $170.98K 10-Q · filed 2021-08-11 | $256.48K derived: sum of 3 quarters · filed 2021-08-11 | $341.97K derived: sum of 4 quarters · filed 2021-08-11 |
| 2021-03-31 | $85.49K 10-Q · filed 2021-05-12 | $170.98K derived: sum of 2 quarters · filed 2021-05-12 | $256.48K derived: sum of 3 quarters · filed 2021-05-12 | $341.97K derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-12-31 | $85.49K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $170.98K derived: sum of 2 quarters · filed 2021-03-31 | $256.48K derived: sum of 3 quarters · filed 2021-03-31 | $341.97K 10-K · filed 2021-03-31 |
| 2020-09-30 | $85.49K 10-Q · filed 2020-11-17 | $170.98K derived: sum of 2 quarters · filed 2020-11-17 | $256.48K 10-Q · filed 2020-11-17 | $341.97K derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-06-30 | $85.49K 10-Q · filed 2020-08-14 | $170.98K 10-Q · filed 2020-08-14 | $256.48K derived: sum of 3 quarters · filed 2021-05-12 | $341.97K derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-03-31 | $85.49K 10-Q · filed 2021-05-12 | $170.98K derived: sum of 2 quarters · filed 2021-05-12 | $256.48K derived: sum of 3 quarters · filed 2021-05-12 | $341.97K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $85.49K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-18 | $170.98K derived: sum of 2 quarters · filed 2020-03-18 | $256.48K derived: sum of 3 quarters · filed 2020-03-18 | $341.97K 10-K · filed 2020-03-18 |
| 2019-09-30 | $85.49K 10-Q · filed 2019-10-31 | $170.98K derived: sum of 2 quarters · filed 2019-10-31 | $256.48K 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $85.49K 10-Q · filed 2019-08-05 | $170.98K 10-Q · filed 2019-08-05 | ||
| 2019-03-31 | $84.49K 10-Q · filed 2020-06-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |